Date: May 1, 2019
Location: 255 Homestead Avenue, Hartford, CT 06132
COURSE DESCRIPTION & OVERALL GOAL
This purpose of this training is to strengthen providers’ knowledge of TB diagnosis, treatment, and management. The conference will provide an opportunity to discuss current and emerging issues in TB. Topics will include current updates in TB, interfacing between the clinician and the lab, new drug trials for LTBI, whole genome sequencing, management of adverse drug reactions, and guidelines for screening of healthcare personnel.
WHO SHOULD ATTEND
This conference is primarily designed for healthcare providers who are involved in the diagnosis, treatment, and management of persons with latent TB infection and disease. The content will be applicable for physicians, physician assistants, nurse practitioners, fellows, and residents. Public health nurses and others working in TB control are welcome to attend.
WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.
OBJECTIVES
Upon completion of this conference, participants should be better able to:
COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire meeting, and complete an evaluation. A credit letter will be mailed to participants within 2 months of the meeting. Participants will also be asked to complete a follow-up evaluation within this time frame.
CONTINUING EDUCATION INFORMATION
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the New England TB Consortium. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 5.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.
DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.
REGISTRATION INFORMATION & FEE
The registration deadline is April 19, 2019. The fee for this course is $30 and payment must be received by April 26th. Acceptable forms of payment are credit card, check, money order or purchase order. Check or money order can be made payable to Rutgers Global Tuberculosis Institute and mailed to:
Attention: Glynis Sanders
Global Tuberculosis Institute
225 Warren Street, 2nd Floor, East Wing
Newark, NJ 07103
Conference Registration Page
TRAVEL INFORMATION & DIRECTIONS
The conference will be held at:
Training & Conference Center at the Chrysalis Center
255 Homestead Avenue
Hartford, CT 06132
Directions can be found at: https://chrysaliscenterct.org/directions/
CANCELLATION INFORMATION
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.
FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.
If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Anita Khilall at anita.khilall@rutgers.edu
FACULTY John Bernardo, MD Robert Horsburgh, MD Lynn Sosa, MD Jeanne Sullivan Meissner, MPH Elizabeth Talbot, MD |
PLANNING COMMITTEE John Bernardo, MD Pat Iyer, MSN, RN, BC Anita Khilall, MPH - Activity Director Darlene Morse, RN, MSN Laura Ann Nicolai, MPH Lynn Sosa, MD |
© 2023, Rutgers, The State University of New Jersey. All rights reserved.
225 Warren Street, Newark, New Jersey 07103
973-972-3270
globaltbinstitute@njms.rutgers.edu
